Automated keratometry gives better results than Scheimpflug keratometry

Article

Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry.

Conventional automated keratometry is better at measuring refractive outcomes after cataract surgery than pupil-based Scheimpflug keratometry, according to a study published in the Journal of Cataract and Refractive Surgery.

Dr Sheridan Lam et al., DuPage Ophthalmology, Lombard, Illinois, USA, conducted a comparative case series on 110 eyes of 76 virgin cornea patients (Group 1) and 137 eyes of 94 control group participants also with virgin corneas (Group 2). Each group underwent phacoemulsification with implantation of a posterior chamber intraocular lens (IOL) and ultrasound biometry.

Group 1 underwent Scheimpflug keratometry based on pupil size and group 2 had conventional automated keratometry. The Holladay 2 formula was used to evaluate IOL power. Refractive outcomes and keratometry (K) readings were assessed by statistical analysis.

In group 1 the mean K reading and mean absolute refractive error was 43.45 D and 0.480 D, respectively. In group 2 it was 43.51 D and 0.252 D, respectively- meaning the absolute refractive error between the two groups was statistically significant.

Of the 110 eyes studied in group 1, 77 were within ±0.50 D of the intended postoperative refraction, 28 were between ±0.50 D and ±1.00 D, 4 were between ±1.00 D and ±1.50 D, and 1 was between ±1.50 D and ±2.00 D. Group 2 saw 131 eyes within ±0.50 D, 3 were between ±0.50 D and ±1.00 D, and 3 were between ±1.00 D and ±1.50 D. The findings were described as statistically significant between the 2 groups.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.